Carl Walkey Neoleukin Therapeutics, Inc. (NLTX) insider trading activity

NLTX Quotes by TradingView

Carl Walkey is Senior Vice President of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 1.35 Million shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2021, when has been sold 600 shares (Common Stock) at a price of $10.19 per share, resulting in proceeds of $6,114. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.35M
0% 3M change
0% 12M change
Total Value Held $0

Carl Walkey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2021
SELL
Open market or private sale
$6,114 $10.19 p/Share
600 Reduced 0.04%
1,352,489 Common Stock
Jun 09 2021
SELL
Open market or private sale
$7,033 $10.82 p/Share
650 Reduced 0.05%
1,353,089 Common Stock
Jun 08 2021
SELL
Open market or private sale
$6,600 $11.0 p/Share
600 Reduced 0.04%
1,353,739 Common Stock
Jun 04 2021
SELL
Open market or private sale
$6,000 $10.0 p/Share
600 Reduced 0.04%
1,354,339 Common Stock
May 26 2021
SELL
Open market or private sale
$6,000 $10.0 p/Share
600 Reduced 0.04%
1,354,939 Common Stock
May 19 2021
SELL
Open market or private sale
$6,378 $10.63 p/Share
600 Reduced 0.04%
1,355,539 Common Stock
May 12 2021
SELL
Open market or private sale
$13,308 $11.09 p/Share
1,200 Reduced 0.09%
1,354,762 Common Stock
May 05 2021
SELL
Open market or private sale
$13,560 $11.3 p/Share
1,200 Reduced 0.09%
1,355,962 Common Stock
Apr 28 2021
SELL
Open market or private sale
$30,192 $12.58 p/Share
2,400 Reduced 0.18%
1,357,162 Common Stock
Apr 26 2021
SELL
Open market or private sale
$7,800 $13.0 p/Share
600 Reduced 0.04%
1,359,562 Common Stock
Apr 21 2021
SELL
Open market or private sale
$21,564 $11.98 p/Share
1,800 Reduced 0.13%
1,360,162 Common Stock
Apr 14 2021
SELL
Open market or private sale
$21,996 $12.22 p/Share
1,800 Reduced 0.13%
1,361,962 Common Stock
Apr 07 2021
SELL
Open market or private sale
$21,636 $12.02 p/Share
1,800 Reduced 0.13%
1,363,762 Common Stock
Apr 05 2021
SELL
Open market or private sale
$7,800 $13.0 p/Share
600 Reduced 0.04%
1,365,562 Common Stock
Mar 31 2021
SELL
Open market or private sale
$21,528 $11.96 p/Share
1,800 Reduced 0.13%
1,366,162 Common Stock
Mar 24 2021
SELL
Open market or private sale
$21,510 $11.95 p/Share
1,800 Reduced 0.13%
1,367,962 Common Stock
Mar 22 2021
SELL
Open market or private sale
$7,200 $12.0 p/Share
600 Reduced 0.04%
1,369,762 Common Stock
Mar 17 2021
SELL
Open market or private sale
$13,632 $11.36 p/Share
1,200 Reduced 0.09%
1,370,362 Common Stock
Mar 10 2021
SELL
Open market or private sale
$21,546 $11.97 p/Share
1,800 Reduced 0.13%
1,371,562 Common Stock
Mar 03 2021
SELL
Open market or private sale
$21,366 $11.87 p/Share
1,800 Reduced 0.13%
1,373,362 Common Stock
Feb 25 2021
SELL
Open market or private sale
$7,800 $13.0 p/Share
600 Reduced 0.04%
1,375,162 Common Stock
Feb 24 2021
SELL
Open market or private sale
$21,852 $12.14 p/Share
1,800 Reduced 0.13%
1,375,762 Common Stock
Feb 17 2021
SELL
Open market or private sale
$30,480 $12.7 p/Share
2,400 Reduced 0.17%
1,377,562 Common Stock
Feb 10 2021
SELL
Open market or private sale
$42,600 $14.2 p/Share
3,000 Reduced 0.22%
1,379,962 Common Stock
Feb 05 2021
SELL
Open market or private sale
$8,400 $14.0 p/Share
600 Reduced 0.04%
1,382,962 Common Stock
CW

Carl Walkey

Senior Vice President
Seattle, WA

Track Institutional and Insider Activities on NLTX

Follow Neoleukin Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NLTX shares.

Notify only if

Insider Trading

Get notified when an Neoleukin Therapeutics, Inc. insider buys or sells NLTX shares.

Notify only if

News

Receive news related to Neoleukin Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NLTX